Nevermind Currency Impact, Johnson & Johnson Is Responding To Other Challenges Reasonably Well

As expected, the strengthening dollar impacted the company's revenue growth significantly and the situation is unlikely to change this year. In addition, the decline in Olysio's sales continued dampening pharmaceutical division's momentum. While the impact of currency was huge, it is something that is transient and not specific to J&J. We expect most big pharmaceutical firms to suffer in a similar way. It is more important to understand J&J's operational growth challenges in pharmaceutical and m...